Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

All MBC

• • Cancer Support Community Online Survey: The Cancer Experience Registry

Triple Negative

• • ADCT-301 in Patients With Advanced Triple Negative Breast Cancer  
  • Anetumab Ravtansine in Advanced Triple Negative Tumors That Are Mesothelin-Positive  
  • A Vaccine-Based Immunotherapy For Stage IV Triple Negative Breast Cancer 
  • Durvalumab & Olaparib in Advanced Triple Negative Breast Cancer Treated with Chemotherapy
  • LAG525 plus Spartalizumab or Carboplatin in Advanced Triple-Negative Breast Cancer
  • Tavo and Pembrolizumab (Immunotherapy) in Advanced Triple Negative Tumors  

BRCA1/2 Mutation

• • Lurbinectedin to Treat Metastatic Breast Cancer in Women & Men with BRCA1/2 Mutations 

Brain Metastasis

• • Methotrexate in Patients With Metastatic Breast Cancer and Leptomeningeal Metastasis 
  • Pembrolizumab (Immunotherapy) And Radiosurgery (Radiation) to Treat Brain Metastases

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.

Last Modified on August 25, 2020